BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 36961094)

  • 1. Treatment of new onset refractory status epilepticus/febrile infection-related epilepsy syndrome with tocilizumab in a child and a young adult.
    Girardin ML; Flamand T; Roignot O; Abi Warde MT; Mutschler V; Voulleminot P; Guillot M; Dinkelacker V; De Saint-Martin A
    Epilepsia; 2023 Jun; 64(6):e87-e92. PubMed ID: 36961094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Febrile Infection-Related Epilepsy Syndrome (FIRES): An Overview of Treatment and Recent Patents.
    Hon KL; Leung AKC; Torres AR
    Recent Pat Inflamm Allergy Drug Discov; 2018; 12(2):128-135. PubMed ID: 29745347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Febrile infection-related epilepsy syndrome (FIRES) with super-refractory status epilepticus revealing autoimmune encephalitis due to GABA
    Caputo D; Iorio R; Vigevano F; Fusco L
    Eur J Paediatr Neurol; 2018 Jan; 22(1):182-185. PubMed ID: 29203057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Febrile infection-related Epilepsy Syndrome (FIRES): a severe encephalopathy with status epilepticus. Literature review and presentation of two new cases.
    Pavone P; Corsello G; Raucci U; Lubrano R; Parano E; Ruggieri M; Greco F; Marino S; Falsaperla R
    Ital J Pediatr; 2022 Dec; 48(1):199. PubMed ID: 36527084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabidiol in the acute phase of febrile infection-related epilepsy syndrome (FIRES).
    Fetta A; Crotti E; Campostrini E; Bergonzini L; Cesaroni CA; Conti F; Di Pisa V; Gentile V; Mondardini MC; Vezzoli C; Giordano L; Cordelli DM
    Epilepsia Open; 2023 Jun; 8(2):685-691. PubMed ID: 37042946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): State of the art and perspectives.
    Gaspard N; Hirsch LJ; Sculier C; Loddenkemper T; van Baalen A; Lancrenon J; Emmery M; Specchio N; Farias-Moeller R; Wong N; Nabbout R
    Epilepsia; 2018 Apr; 59(4):745-752. PubMed ID: 29476535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of febrile infection-related epilepsy syndrome (FIRES) in young adult: still a diagnostic and therapeutic challenge.
    Acampora R; Quiroga Subirana P; Durante L; Tonziello R; Aversano G; Lieto M; Ripa P; Mazzaferro MP
    Neurol Sci; 2022 Jul; 43(7):4555-4558. PubMed ID: 35507191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of patients with new onset refractory status epilepticus preceded by fever (febrile infection-related epilepsy syndrome) versus without prior fever: An interim analysis.
    Jimenez AD; Gopaul M; Asbell H; Aydemir S; Basha MM; Batra A; Damien C; Day GS; Eka O; Eschbach K; Fatima S; Fields MC; Foreman B; Gerard EE; Gofton TE; Haider HA; Hantus ST; Hocker S; Jongeling A; Kalkach Aparicio M; Kandula P; Kang P; Kazazian K; Kellogg MA; Kim M; Lee JW; Marcuse LV; McGraw CM; Mohamed W; Orozco J; Pimentel C; Punia V; Ramirez AM; Steriade C; Struck AF; Taraschenko O; Treister AK; Yoo JY; Zafar S; Zhou DJ; Zutshi D; Gaspard N; Hirsch LJ; Hanin A
    Epilepsia; 2024 Jun; 65(6):e87-e96. PubMed ID: 38625055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New-onset refractory status epilepticus and febrile infection-related epilepsy syndrome.
    Sculier C; Gaspard N
    Curr Opin Neurol; 2023 Apr; 36(2):110-116. PubMed ID: 36762646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe, Refractory Seizures: New-Onset Refractory Status Epilepticus and Febrile Infection-Related Epilepsy Syndrome.
    Carson R; Stredny CM
    Med Clin North Am; 2024 Jan; 108(1):201-213. PubMed ID: 37951651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions.
    Hirsch LJ; Gaspard N; van Baalen A; Nabbout R; Demeret S; Loddenkemper T; Navarro V; Specchio N; Lagae L; Rossetti AO; Hocker S; Gofton TE; Abend NS; Gilmore EJ; Hahn C; Khosravani H; Rosenow F; Trinka E
    Epilepsia; 2018 Apr; 59(4):739-744. PubMed ID: 29399791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-line immunotherapy in new onset refractory status epilepticus.
    Hanin A; Muscal E; Hirsch LJ
    Epilepsia; 2024 May; 65(5):1203-1223. PubMed ID: 38430119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES) of unknown aetiology: A comparison of the incomparable?
    Nausch E; Schaffeldt L; Tautorat I; Margraf NG; Häusler M; Kluger G; Kellinghaus C; Borzikowsky C; Laufs H; van Baalen A
    Seizure; 2022 Mar; 96():18-21. PubMed ID: 35042004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vagus nerve stimulation for super-refractory status epilepticus in febrile infection-related epilepsy syndrome: a pediatric case report and literature review.
    Luo T; Wang Y; Lu G; Zhou Y; Wang Y
    Childs Nerv Syst; 2022 Jul; 38(7):1401-1404. PubMed ID: 34762158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anakinra and tocilizumab in the chronic phase of febrile infection-related epilepsy syndrome (FIRES): Effectiveness and safety from a case-series.
    Aledo-Serrano A; Hariramani R; Gonzalez-Martinez A; Álvarez-Troncoso J; Toledano R; Bayat A; Garcia-Morales I; Becerra JL; Villegas-Martínez I; Beltran-Corbellini A; Gil-Nagel A
    Seizure; 2022 Aug; 100():51-55. PubMed ID: 35759951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical presentation of new onset refractory status epilepticus in children (the pSERG cohort).
    Sculier C; Barcia Aguilar C; Gaspard N; Gaínza-Lein M; Sánchez Fernández I; Amengual-Gual M; Anderson A; Arya R; Burrows BT; Brenton JN; Carpenter JL; Chapman KE; Clark J; Gaillard WD; Glauser TA; Goldstein JL; Goodkin HP; Gorman M; Lai YC; McDonough TL; Mikati MA; Nayak A; Peariso K; Riviello J; Rusie A; Sperberg K; Stredny CM; Tasker RC; Tchapyjnikov D; Vasquez A; Wainwright MS; Wilfong AA; Williams K; Loddenkemper T;
    Epilepsia; 2021 Jul; 62(7):1629-1642. PubMed ID: 34091885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposal to optimize evaluation and treatment of Febrile infection-related epilepsy syndrome (FIRES): A Report from FIRES workshop.
    Koh S; Wirrell E; Vezzani A; Nabbout R; Muscal E; Kaliakatsos M; Wickström R; Riviello JJ; Brunklaus A; Payne E; Valentin A; Wells E; Carpenter JL; Lee K; Lai YC; Eschbach K; Press CA; Gorman M; Stredny CM; Roche W; Mangum T
    Epilepsia Open; 2021 Mar; 6(1):62-72. PubMed ID: 33681649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabidiol as a Potential Treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the Acute and Chronic Phases.
    Gofshteyn JS; Wilfong A; Devinsky O; Bluvstein J; Charuta J; Ciliberto MA; Laux L; Marsh ED
    J Child Neurol; 2017 Jan; 32(1):35-40. PubMed ID: 27655472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A practical approach to in-hospital management of new-onset refractory status epilepticus/febrile infection related epilepsy syndrome.
    Sheikh Z; Hirsch LJ
    Front Neurol; 2023; 14():1150496. PubMed ID: 37251223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New-onset refractory status epilepticus and febrile infection-related epilepsy syndrome.
    Specchio N; Pietrafusa N
    Dev Med Child Neurol; 2020 Aug; 62(8):897-905. PubMed ID: 32372459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.